First Approval Globally For Gilteritinib, In Japan For AML

 
• By Ian Haydock
  
Red Approved Stamp with Wooden handle Rubber Stamper Isolated on White Background.
FIRST APPROVAL FOR ASTELLAS'S AML DRUG, IN JAPAN • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Japan

More from Focus On Asia